Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alendronate for Vascular Calcification and BMD in Peritoneal Dialysis
NCT00261625Phase 4Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Aug 2005
- Primary completion
- Oct 2007
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of alendronate in Vascular calcification and osteoporosis (2 arms), sponsored by National Taiwan University Hospital. Primary endpoints: Extent of aortic and coronary artery calcification at 48 weeks and Bone Mineral Density at 48 weeks. Started Aug 2005; status: completed.
02
Drugs
alendronate
03
Conditions
Vascular calcificationosteoporosis
Beyond the preview
Go deeper on NCT00261625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00261625.